Abeona Therapeutics (FRA:PCJ) Total Stockholders Equity : €-8.17 Mil (As of Mar. 2024)

View and export this data going back to 1980. Start your Free Trial

What is Abeona Therapeutics Total Stockholders Equity?

Abeona Therapeutics's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €-8.17 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Abeona Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 was €-0.30. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Abeona Therapeutics's Debt-to-Equity for the quarter that ended in Mar. 2024 was -2.61.

Abeona Therapeutics Total Stockholders Equity Historical Data

The historical data trend for Abeona Therapeutics's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abeona Therapeutics Total Stockholders Equity Chart

Abeona Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

160.59

84.30

37.50

25.26

13.60

Abeona Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															17.50	8.63	20.65	13.60	-8.17

Abeona Therapeutics (FRA:PCJ) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Abeona Therapeutics's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-8.171	-	0)	/	27.5506
	=	-0.30

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Abeona Therapeutics's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.96	+	20.355)	/	-8.171
	=	-2.61

Abeona Therapeutics Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Abeona Therapeutics's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Abeona Therapeutics (FRA:PCJ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abeona Therapeutics Inc (FRA:PCJ) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ABEO:USA

Address

1330 Avenue of the Americas, 33rd Floor, New York, NY, USA, 10019

Website

https://www.abeonatherapeutics.com

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its lead clinical programs consist of EB-101, autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, adeno-associated virus-based gene therapy for Sanfilippo syndrome type A, and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B.

Abeona Therapeutics (FRA:PCJ) Headlines

No Headlines